|
|
Previous Article | Table of Contents | Next Article 
Blood, 1 April 2001, Vol. 97, No. 7, pp. 1968-1974
HEMATOPOIESIS
Erythroblasts are a source of angiogenic factors
Rafaèle Tordjman,
Stéphanie Delaire,
Jean Plouët,
Stephen Ting,
Philippe Gaulard,
Serge Fichelson,
Paul-Henri Roméo, and
Valérie Lemarchandel
From Institut National de la Santé et de la
Recherche Médicale (INSERM) U474, Maternité Port-Royal, and
Laboratoire d'Hématopoïèse, Site Transfusionnel,
Hôpital Cochin, Paris, France; INSERM U448 and Département
de Pathologie EA 2348, Hôpital Mondor, Créteil, France;
IPBS, GDR 1927, Centre National de la Recherche Scientifique UPR 9062, Toulouse, France.
In adult bone marrow, mature erythroblasts are produced
within structures called erythroblastic islands and then cross the endothelial barrier to reach circulation. Erythroblastic islands are
composed of a central macrophage surrounded by maturing erythroblasts. In this study, it is shown that erythroid cells, but not the
other mature hematopoietic cells, coexpress 2 angiogenic factors,
vascular endothelial growth factor A (VEGF-A) and placenta growth
factor (PlGF). Secretion of both VEGF-A and PlGF increases during in vitro erythroid differentiation. Erythroblast-conditioned medium can
induce both migration of monocytes and endothelial cells and the
permeability of endothelial cells. These effects are inhibited by
anti-PlGF and/or anti-VEGF antibodies. Finally, it is shown that VEGF-A
and PlGF proteins are expressed by bone marrow erythroblasts in vivo.
Angiogenic factors secreted by erythroblasts may promote interactions
either with macrophages in erythroblastic islands or with endothelial
cells that would facilitate the passage of erythroid cells through the
endothelial barrier.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
N. Patel, C. S. Gonsalves, M. Yang, P. Malik, and V. K. Kalra
Placenta growth factor induces 5-lipoxygenase-activating protein to increase leukotriene formation in sickle cell disease
Blood,
January 29, 2009;
113(5):
1129 - 1138.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Telen
It really IS the red cell
Blood,
August 1, 2008;
112(3):
459 - 460.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Chasis and N. Mohandas
Erythroblastic islands: niches for erythropoiesis
Blood,
August 1, 2008;
112(3):
470 - 478.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Patel, C. S. Gonsalves, P. Malik, and V. K. Kalra
Placenta growth factor augments endothelin-1 and endothelin-B receptor expression via hypoxia-inducible factor-1{alpha}
Blood,
August 1, 2008;
112(3):
856 - 865.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. He, H. Hu, R. Braren, S.-Y. Fong, A. Trumpp, T. R. Carlson, and R. A. Wang
c-myc in the hematopoietic lineage is crucial for its angiogenic function in the mouse embryo
Development,
July 15, 2008;
135(14):
2467 - 2477.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Basu, T. K. Lung, W. Lemsaddek, T. G. Sargent, D. C. Williams Jr, M. Basu, L. C. Redmond, J. B Lingrel, J. L. Haar, and J. A. Lloyd
EKLF and KLF2 have compensatory roles in embryonic {beta}-globin gene expression and primitive erythropoiesis
Blood,
November 1, 2007;
110(9):
3417 - 3425.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Christov, F. Chretien, R. Abou-Khalil, G. Bassez, G. Vallet, F.-J. Authier, Y. Bassaglia, V. Shinin, S. Tajbakhsh, B. Chazaud, et al.
Muscle Satellite Cells and Endothelial Cells: Close Neighbors and Privileged Partners
Mol. Biol. Cell,
April 1, 2007;
18(4):
1397 - 1409.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sasaki, T. Inoguchi, K. Muta, Y. Abe, M. Zhang, K. Hiasa, K. Egashira, N. Sonoda, K. Kobayashi, R. Takayanagi, et al.
Therapeutic angiogenesis by ex vivo expanded erythroid progenitor cells
Am J Physiol Heart Circ Physiol,
January 1, 2007;
292(1):
H657 - H665.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Hofmann, K. C. Wollert, G. P. Meyer, A. Menke, L. Arseniev, B. Hertenstein, A. Ganser, W. H. Knapp, and H. Drexler
Monitoring of Bone Marrow Cell Homing Into the Infarcted Human Myocardium
Circulation,
May 3, 2005;
111(17):
2198 - 2202.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Menier, M. Rabreau, J.-C. Challier, M. Le Discorde, E. D. Carosella, and N. Rouas-Freiss
Erythroblasts secrete the nonclassical HLA-G molecule from primitive to definitive hematopoiesis
Blood,
November 15, 2004;
104(10):
3153 - 3160.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Carotta, S. Pilat, A. Mairhofer, U. Schmidt, H. Dolznig, P. Steinlein, and H. Beug
Directed differentiation and mass cultivation of pure erythroid progenitors from mouse embryonic stem cells
Blood,
September 15, 2004;
104(6):
1873 - 1880.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Adams, K. Lenk, A. Linke, D. Lenz, S. Erbs, M. Sandri, A. Tarnok, S. Gielen, F. Emmrich, G. Schuler, et al.
Increase of Circulating Endothelial Progenitor Cells in Patients with Coronary Artery Disease After Exercise-Induced Ischemia
Arterioscler Thromb Vasc Biol,
April 1, 2004;
24(4):
684 - 690.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Perelman, S. K. Selvaraj, S. Batra, L. R. Luck, A. Erdreich-Epstein, T. D. Coates, V. K. Kalra, and P. Malik
Placenta growth factor activates monocytes and correlates with sickle cell disease severity
Blood,
August 15, 2003;
102(4):
1506 - 1514.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. K. Selvaraj, R. K. Giri, N. Perelman, C. Johnson, P. Malik, and V. K. Kalra
Mechanism of monocyte activation and expression of proinflammatory cytochemokines by placenta growth factor
Blood,
August 15, 2003;
102(4):
1515 - 1524.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. S. Torry, D. Mukherjea, J. Arroyo, and R. J. Torry
Expression and Function of Placenta Growth Factor: Implications for Abnormal Placentation
Reproductive Sciences,
May 1, 2003;
10(4):
178 - 188.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Yamada, Y. Oike, H. Ogawa, Y. Ito, H. Fujisawa, T. Suda, and N. Takakura
Neuropilin-1 on hematopoietic cells as a source of vascular development
Blood,
March 1, 2003;
101(5):
1801 - 1809.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Casella, T. Feccia, C. Chelucci, P. Samoggia, G. Castelli, R. Guerriero, I. Parolini, E. Petrucci, E. Pelosi, O. Morsilli, et al.
Autocrine-paracrine VEGF loops potentiate the maturation of megakaryocytic precursors through Flt1 receptor
Blood,
February 15, 2003;
101(4):
1316 - 1323.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. GREUB and D. RAOULT
Bartonella: new explanations for old diseases
J. Med. Microbiol.,
November 1, 2002;
51(11):
915 - 923.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Levy, C. Neuveut, C.-A. Renard, P. Charneau, S. Branchereau, F. Gauthier, J. T. Van Nhieu, D. Cherqui, A.-F. Petit-Bertron, D. Mathieu, et al.
Transcriptional Activation of Interleukin-8 by beta -Catenin-Tcf4
J. Biol. Chem.,
October 25, 2002;
277(44):
42386 - 42393.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Wang, N. Miura, A. Bonelli, P. Mole, N. Carlesso, D. P. Olson, and D. T. Scadden
Receptor tyrosine kinase, EphB4 (HTK), accelerates differentiation of select human hematopoietic cells
Blood,
April 15, 2002;
99(8):
2740 - 2747.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Klasa, A. F. List, and B. D. Cheson
Rational Approaches to Design of Therapeutics Targeting Molecular Markers
Hematology,
January 1, 2001;
2001(1):
443 - 462.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|